Full-Time
Confirmed live in the last 24 hours
Computational platform for biopharmaceutical research
Mid
United Kingdom
Schrödinger provides a computational platform that aids in the research efforts of biopharmaceutical companies, academic institutions, and government laboratories around the world. Their platform offers advanced computational tools that help in drug discovery and research across various therapeutic areas. Schrödinger's products work by utilizing sophisticated algorithms and simulations to predict molecular behavior, which assists researchers in understanding how different compounds can affect biological systems. What sets Schrödinger apart from its competitors is its extensive global reach, serving clients in over 70 countries, and its dual focus on both software licensing and collaborative drug discovery programs. The company's goal is to advance scientific research and innovation by providing powerful tools and services that enhance the drug discovery process.
Company Stage
IPO
Total Funding
$362.7M
Headquarters
New York City, New York
Founded
1990
Help us improve and share your feedback! Did you find this helpful?